Large-scale testing (Phase 3)Not Yet RecruitingNCT06291103
What this trial is testing
Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)
Who this might be right for
Kidney Transplant Rejection
University Hospital, Rouen 290